Market Cap ₹93 Cr.
Stock P/E 0.0
P/B 3.7
Current Price ₹120
Book Value ₹ 32.2
Face Value 10
52W High ₹166.7
Dividend Yield 0%
52W Low ₹ 100.7
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 19 | 23 | 35 | 43 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 19 | 23 | 35 | 43 | |
Total Expenditure | 17 | 21 | 31 | 38 | |
Operating Profit | 2 | 2 | 4 | 6 | |
Interest | 1 | 1 | 1 | 1 | |
Depreciation | 0 | 1 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 1 | 3 | 5 | |
Provision for Tax | 0 | -0 | 0 | 1 | |
Profit After Tax | 1 | 1 | 3 | 3 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 1 | 3 | 3 | |
Adjusted Earnings Per Share | 1.7 | 2 | 5.5 | 5.7 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 23% | 31% | 0% | 0% |
Operating Profit CAGR | 50% | 44% | 0% | 0% |
PAT CAGR | 0% | 44% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 44% | 59% | 62% | 62% |
ROCE Average | 22% | 17% | 16% | 16% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 1 | 2 | 5 | 9 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 9 | 9 | 10 | 8 |
Other Non-Current Liabilities | -0 | -0 | -0 | -0 |
Total Current Liabilities | 11 | 14 | 13 | 16 |
Total Liabilities | 21 | 26 | 28 | 32 |
Fixed Assets | 3 | 3 | 2 | 2 |
Other Non-Current Assets | 0 | 0 | 1 | 1 |
Total Current Assets | 18 | 23 | 25 | 29 |
Total Assets | 21 | 26 | 28 | 32 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 |
Cash Flow from Operating Activities | 2 | -3 | -0 | 2 |
Cash Flow from Investing Activities | -1 | -0 | -0 | -0 |
Cash Flow from Financing Activities | -1 | 3 | 0 | -2 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 1 | 1 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 1.74 | 2.04 | 5.51 | 5.75 |
CEPS(Rs) | 2.61 | 3.06 | 6.42 | 6.26 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 2.51 | 4.55 | 10.02 | 16 |
Core EBITDA Margin(%) | 10.71 | 10.15 | 11.89 | 12.94 |
EBIT Margin(%) | 8.6 | 7.91 | 10.74 | 12.4 |
Pre Tax Margin(%) | 5.13 | 4.66 | 8.63 | 10.53 |
PAT Margin (%) | 4.85 | 4.76 | 8.49 | 7.19 |
Cash Profit Margin (%) | 7.28 | 7.13 | 9.89 | 7.83 |
ROA(%) | 4.45 | 4.73 | 11.18 | 10.38 |
ROE(%) | 69.24 | 57.86 | 75.55 | 44.19 |
ROCE(%) | 12.04 | 11.19 | 17.93 | 22.12 |
Receivable days | 148.02 | 145.32 | 104.3 | 96.55 |
Inventory Days | 141.88 | 134.29 | 109.74 | 107.33 |
Payable days | 153.28 | 115.4 | 50.71 | 36.09 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.83 | 0.86 | 0.6 | 0.49 |
EV/Core EBITDA(x) | 7.49 | 8.41 | 4.9 | 3.79 |
Net Sales Growth(%) | 0 | 19.83 | 51.21 | 23.27 |
EBIT Growth(%) | 0 | 10.28 | 105.1 | 42.35 |
PAT Growth(%) | 0 | 17.58 | 169.54 | 4.42 |
EPS Growth(%) | 0 | 17.58 | 169.54 | 4.42 |
Debt/Equity(x) | 9.19 | 6.71 | 3.25 | 1.94 |
Current Ratio(x) | 1.65 | 1.62 | 1.97 | 1.88 |
Quick Ratio(x) | 0.96 | 0.94 | 1.06 | 0.99 |
Interest Cover(x) | 2.48 | 2.43 | 5.09 | 6.64 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 70.04 | 70.04 |
FII | 7.78 | 7.68 |
DII | 0 | 0 |
Public | 22.18 | 22.28 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 0.54 | 0.54 |
FII | 0.06 | 0.06 |
DII | 0 | 0 |
Public | 0.17 | 0.17 |
Others | 0 | 0 |
Total | 0.77 | 0.77 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About